COMBINATIONS OF A MITHRAMYCIN ANALOGUE AND ANOTHER CHEMOTHERAPEUTIC AGENT FOR THE TREATMENT OF TRIPLE NEGATIVE BREAST CANCER

摘要

Antitumor activity of mithramycin analogues in triple negative breast cancer A composition comprising: a) a compound of Formula (I), Formula (I) or a salt, co-crystal or solvate thereof; and b) at least one chemotherapeutic agent, or a salt, co-crystal or solvate thereof, suitable for use in the treatment of breast cancer, preferably triple negative breast cancer.